Byford, Sarah http://orcid.org/0000-0001-7084-1495
Petkova, Hristina
Barrett, Barbara
Ford, Tamsin
Nicholls, Dasha
Simic, Mima
Gowers, Simon
Macdonald, Geraldine
Stuart, Ruth
Livingstone, Nuala
Kelly, Grace
Kelly, Jonathan
Joshi, Kandarp
Smith, Helen
Eisler, Ivan
Funding for this research was provided by:
HSCNI Public Health Agency Research and Development Division (COM/4716/12)
Health Services and Delivery Research Programme (11/1023/17)
Article History
Received: 2 February 2021
Accepted: 10 June 2021
First Online: 26 June 2021
Declarations
:
: The study was approved by the Child and Adolescent Psychiatry Surveillance System Committee, King’s College London Research Ethics Committee [PNM/13/14-105], and the Health Research Authority Confidentiality Advisory Group [CAG 4-03(PR1)/2014]. Health Research Authority approval was for exemption from obtaining participant consent, under Section 251 of the NHS Act 2006, which enables disclosure of confidential patient information where it is not possible to use anonymised information and where seeking consent is not practical.
: Not applicable.
: TF reports she is Chair of the Child and Adolescent Psychiatry Surveillance Service that was used to run part of the study, which is an unpaid position (other than travel expenses). KJ reports that he was principal investigator for the Aberdeen site for a Sunovion sponsored multisite trial on effectiveness of Lurasidone in paediatric schizophrenia. JK reports that Beat has contracts with some NHS Trusts and Clinical Commissioning Groups who provide and commission (respectively) community eating disorders services for children and young people. In these contracts Beat works with the local services to deliver awareness raising training for professionals and in some cases to offer peer coaching for carers. All other authors declare that they have no competing interests.